Race
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs SHHS Visit Number
| Visit 1 | Visit 2 | CVD Outcomes | |
|---|---|---|---|
| Total | 5,804 | - | - |
| No | 5,653 | - | - |
| Yes | 133 | - | - |
| Unknown | 18 | - | - |
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Age at SHHS1
Visit 1
| 35-44 years | 45-54 years | 55-64 years | 65-74 years | 75-84 years | 85 years or older | Total | |
|---|---|---|---|---|---|---|---|
| Total | 342 | 1,017 | 1,769 | 1,617 | 955 | 104 | 5,804 |
| No | 333 | 1,011 | 1,752 | 1,558 | 899 | 100 | 5,653 |
| Yes | 3 | 2 | 14 | 57 | 53 | 4 | 133 |
| Unknown | 6 | 4 | 3 | 2 | 3 | - | 18 |
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Gender
Visit 1
| Male | Female | Total | |
|---|---|---|---|
| Total | 2,765 | 3,039 | 5,804 |
| No | 2,669 | 2,984 | 5,653 |
| Yes | 85 | 48 | 133 |
| Unknown | 11 | 7 | 18 |
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Race
Visit 1
| White | Black | Other | Total | |
|---|---|---|---|---|
| Total | 4,907 | 515 | 382 | 5,804 |
| No | 4,776 | 503 | 374 | 5,653 |
| Yes | 121 | 7 | 5 | 133 |
| Unknown | 10 | 5 | 3 | 18 |